Dunshea F R, Colantoni C, Howard K, McCauley I, Jackson P, Long K A, Lopaticki S, Nugent E A, Simons J A, Walker J, Hennessy D P
Agriculture Victoria, Victorian Institute of Animal Science, Werribee, Australia.
J Anim Sci. 2001 Oct;79(10):2524-35. doi: 10.2527/2001.79102524x.
Peri- and postpubertal boars accumulate substances (e.g., androstenone and skatole) in their fatty tissue that are responsible for boar taint in pork. The objective of this study was to assess the efficacy of a GnRH vaccine, Improvac, in eliminating boar taint. Three hundred male (200 intact boars, 100 barrows) crossbred (Large White x Landrace) pigs were used in a 2 x 3 factorially arranged experiment. The respective factors were sex group (barrows, boars treated with placebo, or boars treated with Improvac) and slaughter age (23 or 26 wk). Vaccines were administered 8 and 4 wk before slaughter. All Improvac-treated pigs exhibited anti-GnRH titers. Testes and bulbo-urethral gland weights in treated pigs were reduced by approximately 50% (P < 0.001) and serum testosterone levels were below 2 ng/mL in the majority of treated boars (94 and 92% across both age groups at 2 and 4 wk, respectively). Boar taint, as assessed by the concentration of androstenone and skatole in s.c. fat, was suppressed to low or undetectable levels in 100% of Improvac-treated boars. No Improvac-treated pigs had significant concentrations of either androstenone (> 1.0 microg/g) or skatole (> 0.20 microg/g). In contrast, 49.5% of placebo-treated controls had significant androstenone and 10.8% had significant skatole levels, resulting in 10% of the control boars with high concentrations of both compounds. The mean concentrations of taint compounds in the Improvac-treated pigs were not significantly different from those in barrows. Improvac-treated boars grew more rapidly (P = 0.051 and < 0.001 for pigs slaughtered at 23 and 26 wk of age, respectively) than control boars over the 4 wk after the secondary vaccination, possibly because of reduced sexual and aggressive activities. Compared with barrows, Improvac-treated boars were leaner and had superior feed conversion efficiency. The vaccine was well tolerated by the pigs, and no observable site reactions could be detected at the time of slaughter. Vaccination of boars with Improvac allows production of heavy boars with improved meat quality through prevention and control of boar taint.
青春期前后的公猪会在其脂肪组织中积累一些物质(如雄烯酮和粪臭素),这些物质会导致猪肉出现公猪膻味。本研究的目的是评估促性腺激素释放激素(GnRH)疫苗Improvac在消除公猪膻味方面的效果。选用300头雄性(200头未阉割公猪、100头去势公猪)杂交(大白猪×长白猪)猪进行一项2×3析因试验。各因素分别为性别组(去势公猪、用安慰剂处理的公猪或用Improvac处理的公猪)和屠宰年龄(23周或26周)。在屠宰前8周和4周接种疫苗。所有用Improvac处理的猪均表现出抗GnRH抗体效价。处理组猪的睾丸和尿道球腺重量减少了约50%(P<0.001),大多数处理组公猪的血清睾酮水平低于2 ng/mL(两个年龄组在接种后2周和4周分别为94%和92%)。通过测定皮下脂肪中雄烯酮和粪臭素的浓度来评估公猪膻味,结果发现100%用Improvac处理的公猪的公猪膻味被抑制到低水平或检测不到的水平。没有用Improvac处理的猪的雄烯酮(>1.0μg/g)或粪臭素(>0.20μg/g)浓度显著升高。相比之下,49.5%用安慰剂处理的对照公猪雄烯酮浓度显著升高,10.8%粪臭素浓度显著升高,导致10%的对照公猪两种化合物浓度都很高。用Improvac处理的猪中异味化合物的平均浓度与去势公猪的无显著差异。在二次接种后的4周内,用Improvac处理的公猪比对照公猪生长更快(23周龄和26周龄屠宰的猪分别为P = 0.051和P<0.001),这可能是由于性活动和攻击行为减少所致。与去势公猪相比,用Improvac处理的公猪更瘦,饲料转化率更高。猪对该疫苗耐受性良好,屠宰时未检测到明显的局部反应。给公猪接种Improvac疫苗可通过预防和控制公猪膻味来生产肉质更好的肥育公猪。